Clinical teams and regulatory professionals are closely watching the development of Liquid IV’s proprietary pre-workout dietary supplement. A new clinical trial, sponsored by the Applied Science & Performance Institute, is gearing up to gather evidence on its impact, including muscle endurance, energy levels, and cognitive function. The study is marked as not yet recruiting but offers intriguing insights into upcoming research for athletic performance and nutritional supplementation.
What are the study details?
This clinical trial focuses on Liquid IV’s pre-workout supplement compared to a placebo control. Participants will undergo physical and cognitive performance tests designed to measure endurance, perceived exertion, mood changes, and energy levels. The study conditions outlined include endurance exercise, exercise performance, and perceived exertion.
The sponsor, Applied Science & Performance Institute, positions this trial as a step toward evidence-based validation of the supplement’s effectiveness. As of November 2025, enrollment has not yet begun, signaling potential recruitment approaches soon under scientific and ethical guidelines.
What outcomes are being evaluated?
The trial aims to assess the acute effects of the pre-workout supplement in three core areas:
- Muscle endurance and strength: Participants will engage in activities that measure physical stamina and repetitive muscle engagement.
- Energy levels: The supplement’s immediate impact on general fatigue and energy perception is a key focus.
- Cognitive performance: Tasks measuring memory, attention span, and overall mental clarity during exercise form part of the analysis.
These primary and secondary outcomes align with international clinical trial standards, ensuring reproducibility and compliance with research norms.
Who could be affected by the findings?
This study has implications for several sectors:
- Sports and fitness professionals: Insights into improved workout performance may influence training regimens and recovery practices.
- Dietary supplement manufacturers: Clinical outcomes could feed into new product development strategies for targeted athletic performance solutions.
- Regulatory teams: Data from the study may inform compliance reviews and marketing claims within dietary supplement regulation frameworks.
Once recruitment commences, the findings will become especially relevant for those monitoring the interplay between nutrition and exercise science.
FAQ
1. When will recruitment begin?
The trial is currently marked as not yet recruiting. Updates on recruitment timelines are likely forthcoming.
2. How is the supplement administered?
Specific administration details will be disclosed closer to participant engagement phases.
3. What differentiates this study?
It aims for a comprehensive understanding of both physical and cognitive effects, blending traditional exercise performance measures with mood and energy evaluations.
Key takeaways
Liquid IV’s planned study offers significant potential to bridge gaps in evaluating nutritional supplements for athletic and cognitive performance. Clinical, regulatory, and sports professionals alike may benefit from observing its outcomes.
Disclaimer
This article is intended for informational purposes only. It does not constitute legal advice. Professionals should rely on official documentation and guidance for regulatory decisions.
Full information
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07225608?term=medical+device